• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PNW
Click for more information
0.00% 22.0¢

PACIFIC STAR NETWORK LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PNW
Ann: Shares Released from Escrow 		14/03/19 0 80
14/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  80 
PNW
News: PNW Pacific Star Network Confirms Fy19 Underlying EBITDA Guidance 		28/02/19 0 58
28/02/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  58 
PNW
Ann: FY19 Guidance Confirmed and 1H19 Financial Results 		28/02/19 0 173
28/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  173 
PNW
Ann: Half Yearly Report and Accounts 		28/02/19 0 71
28/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  71 
PNW
Ann: Results of Meeting 		30/11/18 0 110
30/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  110 
PNW
News: PNW Pacific Star Network Sees FY19 Underlying EBITDA Guidance In Range Of $8.75 Mln To $9.25... 		30/11/18 0 63
30/11/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  63 
PNW
Ann: Chairman's and CEO's Address to Shareholders 		30/11/18 0 137
30/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  137 
PNW
Ann: Annual Report to shareholders 		30/10/18 0 190
30/10/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  190 

See All Discussions arrow Created with Sketch.

Top Stories

Scientific conference spotlights PYC's work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.